S-1/A: SOBR Safe Files Amendment for Resale of Up to 20.6 Million Shares
S-1/A Filing
SOBR Safe, Inc. has filed an amendment to its registration statement for the resale of up to 20,638,326 shares of common stock underlying warrants held by selling securityholders.
Summary
- SOBR Safe, Inc. has filed an amendment to its registration statement for the resale of up to 20,638,326 shares of common stock.
- These shares are issuable upon the exercise of warrants held by selling securityholders, with an exercise price of $0.27 per share.
- The warrants are exercisable immediately and expire in 60 months.
- If all warrants are exercised, these shares would represent approximately 37.3% of the company's current outstanding common stock.
- The company will not receive any proceeds from the resale of these shares.
- Shareholders previously approved a reverse stock split, with a ratio between 1-for-2 and 1-for-150, to be determined by the officers on September 19, 2024, or as soon as practicable thereafter.
- The company faces risks including maintaining its Nasdaq listing and developing and marketing its SOBRsafe platform.
Sentiment
Score: 4
Explanation: The document highlights both opportunities and significant risks, including financial instability and Nasdaq compliance concerns. The potential for growth is tempered by immediate financial challenges.
Positives
- The company has been granted an exception until October 23, 2024, to regain compliance with Nasdaq listing requirements.
- The company has a three-part strategy to generate sales: direct sales, channel partners, and licensing/integration agreements.
- The company possesses patents and pending patent applications related to its SOBRsafe system and related devices.
Negatives
- The company currently has limited revenue and assets and is in an unsound financial condition.
- The company may not be able to maintain its listing on Nasdaq, which could negatively impact the stock price and ability to raise capital.
- The reverse stock split may decrease the liquidity of the shares of common stock.
Risks
- The company may not be able to maintain its listing on Nasdaq due to minimum bid price and stockholders' equity requirements.
- The reverse stock split may decrease the liquidity of the shares of common stock.
- The Selling Securityholders may sell their shares of common stock in the open market, which may cause the stock price to decline.
- The company faces risks in developing devices based on its SOBRsafe platform, as well as in marketing and selling such devices.
Future Outlook
The company is exploring possible integrations with existing telematics systems and licensing by non-competitive third parties and anticipates hiring an expert in licensing and integrations in 2024 to formulate and execute an expansion plan.
Industry Context
The company operates in the alcohol detection market, targeting behavioral health, judicial, alcohol rehabilitation, consumer, facility & fleet, and young driver markets.
Stakeholder Impact
- Shareholders face potential dilution from the exercise of warrants and risks related to the company's financial condition and Nasdaq listing.
- Employees' equity incentives could be affected by the company's stock price and listing status.
- Customers may be impacted by the company's ability to continue developing and marketing its products.
Next Steps
- The company's officers will determine the ratio for the reverse stock split on or as soon as practicable after September 19, 2024.
- The company needs to regain compliance with Nasdaq's Bid Price Requirement and Stockholders Equity Rule by October 23, 2024.
- The company anticipates hiring an expert in licensing and integrations in 2024 to formulate and execute an expansion plan.
Key Dates
| Date | Description |
|---|---|
| September 19, 2011 | Imagine Media, Ltd. acquired approximately 52% of the outstanding shares of TransBiotec, Inc. |
| January 2012 | Imagine Media, Ltd. changed its name to TransBiotec, Inc. and acquired approximately 45% of the remaining outstanding shares of TBT. |
| March 9, 2020 | Board of Directors approved the amendment to the Certificate of Incorporation to change the name from TransBiotec, Inc. to SOBR Safe, Inc. |
| April 24, 2020 | Certificate of Amendment to Certificate of Incorporation became effective with the State of Delaware. |
| May 16, 2023 | SOBR Safe, Inc. common stock began trading on the Nasdaq exchange under the ticker symbol SOBR. |
| June 3, 2024 | Shareholders approved the granting of authority to the Board to amend the articles of incorporation to effect a reverse stock split. |
| June 4, 2024 | Inducement Letter and Common Stock Purchase Warrant dated between the Company and the selling securityholders. |
| August 30, 2024 | Board of Directors approved the granting of authority to the Company's officers to effect a reverse stock split. |
| September 17, 2024 | Date of the prospectus. |
| September 19, 2024 | Date on which the officers may determine the ratio for the reverse stock split. |
| October 23, 2024 | Panel has determined to grant the Company's request for an exception until this date, to regain compliance with the Bid Price Requirement and Stockholders Equity Rule. |
| December 31, 2024 | Deadline for the Board to determine the exact ratio and timing of the reverse stock split. |
Keywords
SOBR Safe, common stock, warrants, resale, reverse stock split, Nasdaq, alcohol detection, SOBRsafe, selling securityholders
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.